Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. XYZResearchreleased the Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Segment Research Report 2022, which aims to sort out the development status and trends of the Contrast Agents for Magnetic Resonance Imaging (MRI) industry at home and abroad, estimate the overall market scale of the Contrast Agents for Magnetic Resonance Imaging (MRI) industry and the market share of major countries, analyze the development potential of each segment of the Contrast Agents for Magnetic Resonance Imaging (MRI) industry, and study and judge the downstream market demand of Contrast Agents for Magnetic Resonance Imaging (MRI) through systematic research, Analyze the competition pattern of Contrast Agents for Magnetic Resonance Imaging (MRI), so as to help solve the pain points of various stakeholders in Contrast Agents for Magnetic Resonance Imaging (MRI) industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Contrast Agents for Magnetic Resonance Imaging (MRI) Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Contrast Agents for Magnetic Resonance Imaging (MRI) Market
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Major Type of Contrast Agents for Magnetic Resonance Imaging (MRI) Covered in XYZResearch report:
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Application Segments Covered in XYZResearch Market
Radiology
Interventional Radiology
Interventional Cardiology
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Value
2.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type
2.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Value (%)
2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Production
2.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Production by Type
2.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Production (%)
3. The Major Driver of Contrast Agents for Magnetic Resonance Imaging (MRI) Industry
3.1 Historical & Forecast Global Contrast Agents for Magnetic Resonance Imaging (MRI) Demand
3.2 Largest Application for Contrast Agents for Magnetic Resonance Imaging (MRI) (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Contrast Agents for Magnetic Resonance Imaging (MRI) Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Contrast Agents for Magnetic Resonance Imaging (MRI) Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price Trend
12.1 Market Price for Each Type of Contrast Agents for Magnetic Resonance Imaging (MRI) in US (2018-2022)
12.2 Market Price for Each Type of Contrast Agents for Magnetic Resonance Imaging (MRI) in Europe (2018-2022)
12.3 Market Price for Each Type of Contrast Agents for Magnetic Resonance Imaging (MRI) in China (2018-2022)
12.4 Market Price for Each Type of Contrast Agents for Magnetic Resonance Imaging (MRI) in Japan (2018-2022)
12.5 Market Price for Each Type of Contrast Agents for Magnetic Resonance Imaging (MRI) in India (2018-2022)
12.6 Market Price for Each Type of Contrast Agents for Magnetic Resonance Imaging (MRI) in Korea (2018-2022)
12.7 Market Price for Each Type of Contrast Agents for Magnetic Resonance Imaging (MRI) in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Contrast Agents for Magnetic Resonance Imaging (MRI)
14. Contrast Agents for Magnetic Resonance Imaging (MRI) Competitive Landscape
14.1 GE Healthcare (US)
14.1.1 GE Healthcare (US) Company Profiles
14.1.2 GE Healthcare (US) Product Introduction
14.1.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Bracco Imaging (Italy)
14.2.1 Bracco Imaging (Italy) Company Profiles
14.2.2 Bracco Imaging (Italy) Product Introduction
14.2.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Bayer HealthCare (Germany)
14.3.1 Bayer HealthCare (Germany) Company Profiles
14.3.2 Bayer HealthCare (Germany) Product Introduction
14.3.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Guerbet (France)
14.4.1 Guerbet (France) Company Profiles
14.4.2 Guerbet (France) Product Introduction
14.4.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Lantheus (US)
14.5.1 Lantheus (US) Company Profiles
14.5.2 Lantheus (US) Product Introduction
14.5.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Daiichi Sankyo (Japan)
14.6.1 Daiichi Sankyo (Japan) Company Profiles
14.6.2 Daiichi Sankyo (Japan) Product Introduction
14.6.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Unijules Life Sciences (India)
14.7.1 Unijules Life Sciences (India) Company Profiles
14.7.2 Unijules Life Sciences (India) Product Introduction
14.7.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 J.B. Chemicals and Pharmaceuticals (India)
14.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Profiles
14.8.2 J.B. Chemicals and Pharmaceuticals (India) Product Introduction
14.8.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Spago Nanomedicine (Sweden)
14.9.1 Spago Nanomedicine (Sweden) Company Profiles
14.9.2 Spago Nanomedicine (Sweden) Product Introduction
14.9.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Taejoon Pharm (South Korea)
14.10.1 Taejoon Pharm (South Korea) Company Profiles
14.10.2 Taejoon Pharm (South Korea) Product Introduction
14.10.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Jodas (India)
14.12 Magnus Health (India)
15. Conclusion